Ownership history in Ghost Tree Capital, LLC · 11 quarters on record
This page tracks every 13F SEC filing in which Ghost Tree Capital, LLC reported a position in MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | REDUCED | 128,411 | -171,589 | -57.2% | 1.96% | $6.5M | $50.42 |
| 2024 Q2 | UNCHANGED | 300,000 | — | 0% | 4.13% | $13.2M | $43.97 |
| 2024 Q1 | ADDED | 300,000 | +220,000 | +275.0% | 4.17% | $15.1M | $50.23 |
| 2023 Q4 | REDUCED | 80,000 | -170,000 | -68.0% | 1.58% | $4.8M | $60.39 |
| 2023 Q4 | UNCHANGED | 250,000 | — | 0% | 4.94% | $15.1M | $60.39 |
| 2023 Q3 | REDUCED | 250,000 | -80,000 | -24.2% | 4.69% | $14.2M | $57.00 |
| 2023 Q3 | UNCHANGED | 330,000 | — | 0% | 6.19% | $18.8M | $57.00 |
| 2023 Q2 | ADDED | 330,000 | +135,000 | +69.2% | 5.56% | $16.8M | $51.00 |
| 2023 Q1 | REDUCED | 195,000 | -105,000 | -35.0% | 1.23% | $4.2M | $21.39 |
| 2022 Q3 | UNCHANGED | 300,000 | — | 0% | 0.65% | $2.3M | $7.76 |
As of 2025 Q4 — sorted by position size